Najlepsi lekarze wykonujący terapię komórkami CAR-T w Ramacie Ganie – TOP 6 lekarzy

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Hana Golan

MD | Pediatric Hematology-Oncology & Bone Marrow Transplant Specialist

Department:

Pediatric Hemato-Oncology & BMT Division, Sheba Medical Center

Languages:

Hebrew, English

Professional Summary

Dr. Hana Golan is a leading pediatric hemato-oncologist and Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant (BMT) Division at Sheba Medical Center. She specializes in the treatment of childhood cancers and complex hematological disorders, with a particular focus on neuroblastoma and high-risk solid tumors.

With decades of clinical and research experience, Dr. Golan combines advanced oncology protocols with personalized treatment strategies aimed at improving outcomes in challenging pediatric cases.

Areas of Expertise

Pediatric oncology (solid tumors and hematologic malignancies)

Neuroblastoma (including high-risk cases)

Bone marrow and stem cell transplantation

Leukemia and lymphoma in children

Chronic and inherited blood disorders

Immune deficiencies and metabolic disorders

Personalized chemotherapy and targeted therapy protocols

Education & Training

MD, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology

Residency in Pediatrics, Sheba Medical Center

Residency in Pediatric Hematology-Oncology, Sheba Medical Center

Advanced research training in transplantation immunology, Weizmann Institute of Science

Additional training in clinical research, biomedical informatics, and healthcare management

Clinical & Research Experience

Dr. Golan leads one of the most advanced pediatric oncology programs in the region, managing complex and high-risk cases. She is actively involved in the development and implementation of international treatment protocols, particularly in neuroblastoma.

Her research focuses on:

cancer stem cells in pediatric tumors

development of targeted therapies

novel approaches to treatment-resistant malignancies

emerging therapeutic strategies, including cannabinoid-related research in oncology

Clinical Trials & International Collaboration

Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol

Investigator in international Phase I/II clinical trials targeting advanced pediatric cancers

National coordinator of multicenter oncology protocols

Academic & Teaching Roles

Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University

Lecturer in pediatric hematology-oncology for physicians and nurses

Coordinator of hematology training programs for medical students

Leadership & Innovation

Director, Pediatric Hemato-Oncology and BMT Division

Led implementation of computerized chemotherapy protocols and patient databases

Developed systems to improve clinical workflow and patient safety

Board Certifications

Pediatrics

Pediatric Hematology-Oncology

Selected Publications

Primary immunodeficiency syndromes in Israel

Integration of palliative care in pediatric oncology

Additional peer-reviewed publications in pediatric cancer treatment

Why Patients Choose Dr. Golan

Extensive experience in complex pediatric oncology cases

Leadership in international clinical trials and treatment protocols

Expertise in neuroblastoma and high-risk pediatric tumors

Multidisciplinary approach combining treatment, research, and supportive care

Practice within a Top-10 globally ranked hospital

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Iris Kventsel, MD

Pediatric Hemato-Oncology & BMT Specialist – Sheba Medical Center

Expert in Pediatric Sarcomas & Advanced Childhood Cancer Care

Dr. Iris Kventsel is a specialized pediatric hemato-oncologist, recognized for her expertise in the treatment of childhood sarcomas and complex pediatric cancers.

She serves as an attending physician in the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center, based within the Edmond and Lily Safra Children’s Hospital, where she provides highly specialized, multidisciplinary care for children and adolescents.

Areas of Expertise

• Pediatric Sarcomas (Primary Focus)
  • Ewing sarcoma
  • Osteosarcoma
  • Rhabdomyosarcoma
• Pediatric Hemato-Oncology
• 
  Diagnosis and treatment of childhood cancers and complex hematologic conditions
•  
• Bone Marrow Transplantation (BMT)
• 
  Part of a leading team providing advanced transplant and cellular therapies
•  
• Advanced Oncology Treatments
• 
  Integration of modern chemotherapy protocols, targeted therapies, and multidisciplinary care

Clinical Excellence & Approach

Dr. Kventsel is known for delivering precise, patient-centered pediatric oncology care, focusing on:

• Individualized treatment plans for each child
•  
• Close collaboration with surgeons, radiologists, and transplant specialists
• Balancing effective cancer treatment with long-term quality of life

Her work is particularly focused on complex and rare pediatric tumors, where expertise and coordinated care are critical.

Academic & Research Activity

Dr. Kventsel is actively involved in clinical research and international scientific collaboration, contributing to advancements in pediatric oncology:

• Research in genetic cancer predisposition syndromes, including Li-Fraumeni syndrome
• Studies on cancer susceptibility genes in pediatric populations
• Participation in clinical trials and innovative treatment protocols
• Publications in pediatric oncology, stem cell biology, and surgical oncology (HIPEC in children)

She also serves on the academic staff of the Tel Aviv University Faculty of Medicine.

Education & Training

• MD, Technion – Israel Institute of Technology
• Residency in Pediatrics, Assaf HaRofeh Medical Center
• Fellowship in Pediatric Hemato-Oncology, Sheba Medical Center

Clinical Environment

Dr. Kventsel treats patients within the Edmond and Lily Safra Children’s Hospital, one of the most advanced pediatric hospitals in the region, offering:

• Multidisciplinary pediatric cancer care
• Access to advanced therapies and clinical trials
• A supportive, child- and family-centered environment

Patient-Centered Care

Dr. Kventsel provides compassionate, highly specialized care for children and their families, combining advanced medical expertise with a deeply personalized approach throughout the treatment journey.

A Trusted Expert in Pediatric Oncology

Through her expertise in childhood sarcomas, advanced therapies, and multidisciplinary care, Dr. Kventsel offers young patients access to one of the most advanced pediatric cancer programs available.